meddevicedb.com FDA Device Reference

ATRILAZE MALLEABLE ABLATION PROBE

K052495 Class II Special
Decision Date
2005-10-11
Sponsor / Applicant
Medical Cv, Inc.

Technical Specification

510(k) Submission ID K052495
Product Code GEX
Medical Specialty / Panel General, Plastic Surgery
Regulation Citation 21 CFR 878.4810
Decision Date 2005-10-11
Clearance Pathway Special

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

ATRILAZE MALLEABLE ABLATION PROBE received FDA 510(k) clearance under submission number K052495, sponsored by Medical Cv, Inc.. The device was reviewed via the Special premarket notification pathway and assigned to the General, Plastic Surgery review panel. The statutory decision date of record is 2005-10-11.

Classification & Regulation

This clearance is catalogued under FDA product code GEX and 21 CFR 878.4810, within the General, Plastic Surgery review panel as a Class II device.